RPCEC00000126已完成2 期
Evaluation of the effect and safety of SURFACEN in the treatment of acute respiratory distress syndrome in adults
ational Centre of Animal and Plants Health(CENSA)0 个研究点目标入组 72 人开始时间: 2012年4月11日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled trial. Masking: Open. Control group: Active. Assignment: Parallel. Purpose: Treatment
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •1. Presenceof ARDS inthe first 24hours ofdiagnosis, diagnostic criteriagivenabove. 2. PEEP> 5 cm H2O. 3. Patientswhose relativesgive theirwritten consentto participatein the study. 4. Age between 18 and 75,inclusive.
排除标准
- •1.Pregnant women, breast feedingor post partum. 2.Chronic Obstructive Pulmonary Disease(COPD). 3.Hipersensibilidad to SURFACEN or other component of the formulation.
研究者
相似试验
招募中
4 期
Early use of surfacen in the respiratory distress syndrome of the newborn. Phase IVewborn Respiratory Distress SyndromeRPCEC00000099ational Center for Animal Plant and Health (CENSA)
已完成
3 期
SURFACEN ARDS. Pediatrics. Phase IIIRespiratory distress syndrome in pediatric patientsRPCEC00000163ational Center for Animal and Plant Health (CENSA)72
招募中
4 期
Safety and effectiveness of SURFACEN® combined with the conventional therapy, in the treatment of ARDS in pediatrics. National extensioAcute Respiratory Distress Syndrome (ARDS)PediatricsRespiratory Distress Syndrome, AdultLung DiseasesRespiratory Tract DiseasesRespiration DisordersRPCEC00000253ational Center for Animal and Plant Health (CENSA)193
招募中
4 期
SURFACEN in ARDS. Adults. Phase IVAcute Respiratory Distress SyndromeRPCEC00000198ational Centre of Animal and Plants Health (CENSA)184
招募中
1 期
Investigating the endolift method in the treatment of primary axillary hyperhidrosisIRCT20200127046282N43Tehran University of Medical Sciences10